

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | epoxygenase P450 pathway (GO:0019373) | 7.50243847 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.29525264 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 7.29525264 |
| 4 | omega-hydroxylase P450 pathway (GO:0097267) | 7.04373817 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.02213099 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 7.02213099 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 6.65396562 |
| 8 | alpha-linolenic acid metabolic process (GO:0036109) | 6.18152311 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 6.05358862 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 6.05358862 |
| 11 | tryptophan catabolic process (GO:0006569) | 6.05358862 |
| 12 | fibrinolysis (GO:0042730) | 6.03737730 |
| 13 | glyoxylate metabolic process (GO:0046487) | 5.98808413 |
| 14 | kynurenine metabolic process (GO:0070189) | 5.91581656 |
| 15 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.79261636 |
| 16 | bile acid biosynthetic process (GO:0006699) | 5.77056324 |
| 17 | cysteine metabolic process (GO:0006534) | 5.74004422 |
| 18 | tryptophan metabolic process (GO:0006568) | 5.72676425 |
| 19 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.62557715 |
| 20 | oxidative demethylation (GO:0070989) | 5.56071741 |
| 21 | blood coagulation, intrinsic pathway (GO:0007597) | 5.46406705 |
| 22 | lysine catabolic process (GO:0006554) | 5.39879305 |
| 23 | lysine metabolic process (GO:0006553) | 5.39879305 |
| 24 | sulfur amino acid catabolic process (GO:0000098) | 5.33076120 |
| 25 | serine family amino acid catabolic process (GO:0009071) | 5.17767135 |
| 26 | urea metabolic process (GO:0019627) | 5.14932416 |
| 27 | urea cycle (GO:0000050) | 5.14932416 |
| 28 | phenylpropanoid metabolic process (GO:0009698) | 5.14051762 |
| 29 | amino-acid betaine metabolic process (GO:0006577) | 5.03623037 |
| 30 | ethanol metabolic process (GO:0006067) | 4.95672039 |
| 31 | homocysteine metabolic process (GO:0050667) | 4.93240281 |
| 32 | bile acid metabolic process (GO:0008206) | 4.93225712 |
| 33 | high-density lipoprotein particle remodeling (GO:0034375) | 4.92468207 |
| 34 | S-adenosylmethionine metabolic process (GO:0046500) | 4.87880109 |
| 35 | cellular ketone body metabolic process (GO:0046950) | 4.87173630 |
| 36 | aromatic amino acid family metabolic process (GO:0009072) | 4.85249883 |
| 37 | negative regulation of fibrinolysis (GO:0051918) | 4.84590557 |
| 38 | intestinal cholesterol absorption (GO:0030299) | 4.76641572 |
| 39 | nitrogen cycle metabolic process (GO:0071941) | 4.75737907 |
| 40 | protein carboxylation (GO:0018214) | 4.72482604 |
| 41 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.72482604 |
| 42 | regulation of plasminogen activation (GO:0010755) | 4.70479044 |
| 43 | regulation of fibrinolysis (GO:0051917) | 4.60629760 |
| 44 | alpha-amino acid catabolic process (GO:1901606) | 4.60580232 |
| 45 | negative regulation of hemostasis (GO:1900047) | 4.58132625 |
| 46 | negative regulation of blood coagulation (GO:0030195) | 4.58132625 |
| 47 | complement activation, alternative pathway (GO:0006957) | 4.54591723 |
| 48 | tyrosine metabolic process (GO:0006570) | 4.53612355 |
| 49 | drug transmembrane transport (GO:0006855) | 4.51391366 |
| 50 | regulation of triglyceride catabolic process (GO:0010896) | 4.49010423 |
| 51 | regulation of protein activation cascade (GO:2000257) | 4.45475577 |
| 52 | negative regulation of sterol transport (GO:0032372) | 4.42664327 |
| 53 | negative regulation of cholesterol transport (GO:0032375) | 4.42664327 |
| 54 | regulation of cholesterol esterification (GO:0010872) | 4.39548249 |
| 55 | reverse cholesterol transport (GO:0043691) | 4.33424585 |
| 56 | drug catabolic process (GO:0042737) | 4.33394031 |
| 57 | serine family amino acid metabolic process (GO:0009069) | 4.33289456 |
| 58 | cellular amino acid catabolic process (GO:0009063) | 4.32249041 |
| 59 | urate metabolic process (GO:0046415) | 4.31157893 |
| 60 | protein-lipid complex remodeling (GO:0034368) | 4.31121916 |
| 61 | macromolecular complex remodeling (GO:0034367) | 4.31121916 |
| 62 | plasma lipoprotein particle remodeling (GO:0034369) | 4.31121916 |
| 63 | glutamate metabolic process (GO:0006536) | 4.31000827 |
| 64 | indolalkylamine metabolic process (GO:0006586) | 4.30888003 |
| 65 | short-chain fatty acid metabolic process (GO:0046459) | 4.29670816 |
| 66 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.27781821 |
| 67 | triglyceride homeostasis (GO:0070328) | 4.26753698 |
| 68 | acylglycerol homeostasis (GO:0055090) | 4.26753698 |
| 69 | flavonoid metabolic process (GO:0009812) | 4.25680110 |
| 70 | daunorubicin metabolic process (GO:0044597) | 4.23191509 |
| 71 | polyketide metabolic process (GO:0030638) | 4.23191509 |
| 72 | doxorubicin metabolic process (GO:0044598) | 4.23191509 |
| 73 | negative regulation of coagulation (GO:0050819) | 4.22591078 |
| 74 | ketone body metabolic process (GO:1902224) | 4.21943045 |
| 75 | cellular modified amino acid catabolic process (GO:0042219) | 4.20536457 |
| 76 | glycine metabolic process (GO:0006544) | 4.20199242 |
| 77 | negative regulation of protein activation cascade (GO:2000258) | 4.19057822 |
| 78 | protein activation cascade (GO:0072376) | 4.18427038 |
| 79 | coenzyme catabolic process (GO:0009109) | 4.16018836 |
| 80 | acetyl-CoA metabolic process (GO:0006084) | 4.15835549 |
| 81 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.15823125 |
| 82 | amine catabolic process (GO:0009310) | 4.15694870 |
| 83 | cellular biogenic amine catabolic process (GO:0042402) | 4.15694870 |
| 84 | regulation of complement activation (GO:0030449) | 4.14621253 |
| 85 | bile acid and bile salt transport (GO:0015721) | 4.14181150 |
| 86 | ethanol oxidation (GO:0006069) | 4.12621968 |
| 87 | benzene-containing compound metabolic process (GO:0042537) | 4.12600301 |
| 88 | phospholipid efflux (GO:0033700) | 4.12074098 |
| 89 | negative regulation of wound healing (GO:0061045) | 4.10349979 |
| 90 | plasma lipoprotein particle clearance (GO:0034381) | 4.05067358 |
| 91 | cellular glucuronidation (GO:0052695) | 4.03417469 |
| 92 | alkaloid metabolic process (GO:0009820) | 4.02459264 |
| 93 | aminoglycoside antibiotic metabolic process (GO:0030647) | 4.01557330 |
| 94 | serine family amino acid biosynthetic process (GO:0009070) | 4.01106967 |
| 95 | response to mercury ion (GO:0046689) | 4.00532007 |
| 96 | * fatty acid beta-oxidation (GO:0006635) | 3.96993170 |
| 97 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.94650806 |
| 98 | negative regulation of lipase activity (GO:0060192) | 3.94132764 |
| 99 | aspartate family amino acid catabolic process (GO:0009068) | 3.93541967 |
| 100 | carnitine metabolic process (GO:0009437) | 3.92862529 |
| 101 | * organic acid catabolic process (GO:0016054) | 3.92142342 |
| 102 | * carboxylic acid catabolic process (GO:0046395) | 3.92142342 |
| 103 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.90160307 |
| 104 | * fatty acid oxidation (GO:0019395) | 3.89758357 |
| 105 | acute-phase response (GO:0006953) | 3.87505459 |
| 106 | cholesterol efflux (GO:0033344) | 3.84830475 |
| 107 | aldehyde catabolic process (GO:0046185) | 3.83508778 |
| 108 | regulation of cholesterol homeostasis (GO:2000188) | 3.82745937 |
| 109 | * lipid oxidation (GO:0034440) | 3.82232263 |
| 110 | positive regulation of blood coagulation (GO:0030194) | 3.81734947 |
| 111 | positive regulation of hemostasis (GO:1900048) | 3.81734947 |
| 112 | 2-oxoglutarate metabolic process (GO:0006103) | 3.80901648 |
| 113 | * monocarboxylic acid catabolic process (GO:0072329) | 3.80613632 |
| 114 | complement activation, classical pathway (GO:0006958) | 3.79886764 |
| 115 | heme transport (GO:0015886) | 3.79575779 |
| 116 | regulation of humoral immune response (GO:0002920) | 3.78501414 |
| 117 | primary alcohol catabolic process (GO:0034310) | 3.77682873 |
| 118 | very long-chain fatty acid metabolic process (GO:0000038) | 3.76101824 |
| 119 | * fatty acid catabolic process (GO:0009062) | 3.76094668 |
| 120 | imidazole-containing compound metabolic process (GO:0052803) | 3.73582969 |
| 121 | hormone catabolic process (GO:0042447) | 3.73282116 |
| 122 | drug transport (GO:0015893) | 3.72976275 |
| 123 | complement activation (GO:0006956) | 3.71811139 |
| 124 | L-methionine salvage (GO:0071267) | 3.70920787 |
| 125 | L-methionine biosynthetic process (GO:0071265) | 3.70920787 |
| 126 | amino acid salvage (GO:0043102) | 3.70920787 |
| 127 | positive regulation of lipid catabolic process (GO:0050996) | 3.70184886 |
| 128 | low-density lipoprotein particle remodeling (GO:0034374) | 3.69734683 |
| 129 | plasma lipoprotein particle assembly (GO:0034377) | 3.69486146 |
| 130 | arginine metabolic process (GO:0006525) | 3.68748392 |
| 131 | phospholipid homeostasis (GO:0055091) | 3.68641343 |
| 132 | glucuronate metabolic process (GO:0019585) | 3.65741947 |
| 133 | uronic acid metabolic process (GO:0006063) | 3.65741947 |
| 134 | exogenous drug catabolic process (GO:0042738) | 3.63498716 |
| 135 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.62635680 |
| 136 | xenobiotic metabolic process (GO:0006805) | 3.60116679 |
| 137 | cholesterol homeostasis (GO:0042632) | 3.57694579 |
| 138 | valine metabolic process (GO:0006573) | 3.56668985 |
| 139 | sterol homeostasis (GO:0055092) | 3.54307124 |
| 140 | drug metabolic process (GO:0017144) | 3.53550941 |
| 141 | positive regulation of coagulation (GO:0050820) | 3.51319133 |
| 142 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.49900175 |
| 143 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.49900175 |
| 144 | sodium-independent organic anion transport (GO:0043252) | 3.49565952 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.27491198 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.11110377 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.49706875 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.43967463 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.26871615 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.03140539 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.65994189 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.94114948 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.71894572 |
| 10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.33924576 |
| 11 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.13478257 |
| 12 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.09813518 |
| 13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.4988244 |
| 14 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.97006058 |
| 15 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.79530360 |
| 16 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.71984191 |
| 17 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.66006074 |
| 18 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.55982939 |
| 19 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.47146912 |
| 20 | GATA1_22025678_ChIP-Seq_K562_Human | 1.41022349 |
| 21 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.39084922 |
| 22 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.38467820 |
| 23 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.36518631 |
| 24 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.35311693 |
| 25 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.31253074 |
| 26 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.15481918 |
| 27 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.12951824 |
| 28 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.12938907 |
| 29 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.12171251 |
| 30 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.10961378 |
| 31 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.10578292 |
| 32 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.08567398 |
| 33 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.07394471 |
| 34 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.06836781 |
| 35 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.06335318 |
| 36 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.05284678 |
| 37 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.04219872 |
| 38 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.03177385 |
| 39 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.03160694 |
| 40 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.02496854 |
| 41 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.01890313 |
| 42 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.00723958 |
| 43 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.00032411 |
| 44 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.99236101 |
| 45 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.99189656 |
| 46 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.97969009 |
| 47 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.96675060 |
| 48 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.95804976 |
| 49 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.93914191 |
| 50 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.91044174 |
| 51 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.90922470 |
| 52 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.88569679 |
| 53 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.88442243 |
| 54 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.87982650 |
| 55 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.87562779 |
| 56 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.87374557 |
| 57 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.87100959 |
| 58 | NFYA_21822215_ChIP-Seq_K562_Human | 0.86999278 |
| 59 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.86307661 |
| 60 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.86232469 |
| 61 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.86030676 |
| 62 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.85446086 |
| 63 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.85116387 |
| 64 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.84903303 |
| 65 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.84903303 |
| 66 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.84417502 |
| 67 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.84377304 |
| 68 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.83731274 |
| 69 | * FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.83291010 |
| 70 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.83040525 |
| 71 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.82523091 |
| 72 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.81698222 |
| 73 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.81473005 |
| 74 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.81473005 |
| 75 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.80688843 |
| 76 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.80669006 |
| 77 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.79982833 |
| 78 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.79248594 |
| 79 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.79141674 |
| 80 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.78925154 |
| 81 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.78851121 |
| 82 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.78662676 |
| 83 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.78622999 |
| 84 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.78483534 |
| 85 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.77212757 |
| 86 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.77021524 |
| 87 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.76978791 |
| 88 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.76643159 |
| 89 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.76591543 |
| 90 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.76588787 |
| 91 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.76251408 |
| 92 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.75971222 |
| 93 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.75872300 |
| 94 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.75509045 |
| 95 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.74892949 |
| 96 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.74692850 |
| 97 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.74680871 |
| 98 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.71888371 |
| 99 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.71718781 |
| 100 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.71109433 |
| 101 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.71105859 |
| 102 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.71105859 |
| 103 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.70615543 |
| 104 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.69758804 |
| 105 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.69674855 |
| 106 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.67321233 |
| 107 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.63600805 |
| 108 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.62878992 |
| 109 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.62557623 |
| 110 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.62183204 |
| 111 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.61618065 |
| 112 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.61578323 |
| 113 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.61334813 |
| 114 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.60946276 |
| 115 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.60698343 |
| 116 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.59245424 |
| 117 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.58240293 |
| 118 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.57462044 |
| 119 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.56541303 |
| 120 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.55117074 |
| 121 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.54441564 |
| 122 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.53608483 |
| 123 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.53190316 |
| 124 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.53029130 |
| 125 | AR_20517297_ChIP-Seq_VCAP_Human | 0.52113255 |
| 126 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.52004543 |
| 127 | CBP_21632823_ChIP-Seq_H3396_Human | 0.50661579 |
| 128 | GATA2_19941826_ChIP-Seq_K562_Human | 0.49977393 |
| 129 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.49490689 |
| 130 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.48861187 |
| 131 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.48761032 |
| 132 | GATA1_19941826_ChIP-Seq_K562_Human | 0.48493553 |
| 133 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.48129396 |
| 134 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.45989489 |
| 135 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.44691893 |
| 136 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.44316913 |
| 137 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.43199444 |
| 138 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.43154483 |
| 139 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.43045968 |
| 140 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.41493572 |
| 141 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.41026464 |
| 142 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.40919033 |
| 143 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.40908885 |
| 144 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.40643330 |
| 145 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.39981707 |
| 146 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.39916615 |
| 147 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.39710062 |
| 148 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.39312877 |
| 149 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.39005718 |
| 150 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.38559514 |
| 151 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.37677995 |
| 152 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.37135393 |
| 153 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.37028613 |
| 154 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.36820813 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.51183983 |
| 2 | MP0005360_urolithiasis | 7.63296035 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.18439168 |
| 4 | * MP0005365_abnormal_bile_salt | 5.84442223 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.92604791 |
| 6 | MP0003252_abnormal_bile_duct | 4.06456451 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.88982087 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.36342891 |
| 9 | MP0005332_abnormal_amino_acid | 3.14165912 |
| 10 | MP0003195_calcinosis | 2.96196398 |
| 11 | MP0005083_abnormal_biliary_tract | 2.95853256 |
| 12 | MP0009840_abnormal_foam_cell | 2.87022616 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.64295023 |
| 14 | MP0004019_abnormal_vitamin_homeostasis | 2.59926518 |
| 15 | MP0002138_abnormal_hepatobiliary_system | 2.38686941 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.18468544 |
| 17 | * MP0002118_abnormal_lipid_homeostasis | 2.09068695 |
| 18 | * MP0000609_abnormal_liver_physiology | 2.05516338 |
| 19 | MP0005451_abnormal_body_composition | 1.99755574 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.82395275 |
| 21 | MP0003868_abnormal_feces_composition | 1.76332569 |
| 22 | MP0009643_abnormal_urine_homeostasis | 1.67218029 |
| 23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.64530883 |
| 24 | MP0001764_abnormal_homeostasis | 1.58394075 |
| 25 | MP0003186_abnormal_redox_activity | 1.36569380 |
| 26 | MP0003011_delayed_dark_adaptation | 1.24380786 |
| 27 | MP0005636_abnormal_mineral_homeostasis | 1.24007078 |
| 28 | MP0009697_abnormal_copulation | 1.23450887 |
| 29 | MP0004043_abnormal_pH_regulation | 1.13615758 |
| 30 | MP0000598_abnormal_liver_morphology | 1.12162692 |
| 31 | MP0001756_abnormal_urination | 1.08015602 |
| 32 | MP0003656_abnormal_erythrocyte_physiolo | 1.06095010 |
| 33 | MP0003705_abnormal_hypodermis_morpholog | 1.02889162 |
| 34 | MP0009764_decreased_sensitivity_to | 1.01041673 |
| 35 | MP0005647_abnormal_sex_gland | 1.00103864 |
| 36 | MP0000604_amyloidosis | 0.98955414 |
| 37 | MP0006036_abnormal_mitochondrial_physio | 0.96680065 |
| 38 | MP0005084_abnormal_gallbladder_morpholo | 0.91861445 |
| 39 | MP0002876_abnormal_thyroid_physiology | 0.91828127 |
| 40 | MP0005670_abnormal_white_adipose | 0.91603940 |
| 41 | MP0009642_abnormal_blood_homeostasis | 0.88112804 |
| 42 | MP0009763_increased_sensitivity_to | 0.88056931 |
| 43 | MP0002136_abnormal_kidney_physiology | 0.87282016 |
| 44 | MP0002254_reproductive_system_inflammat | 0.85516001 |
| 45 | MP0008469_abnormal_protein_level | 0.83922519 |
| 46 | MP0002078_abnormal_glucose_homeostasis | 0.82582679 |
| 47 | MP0002132_abnormal_respiratory_system | 0.80132537 |
| 48 | MP0005535_abnormal_body_temperature | 0.78810392 |
| 49 | MP0005408_hypopigmentation | 0.76415142 |
| 50 | MP0005220_abnormal_exocrine_pancreas | 0.75556702 |
| 51 | MP0004130_abnormal_muscle_cell | 0.75489662 |
| 52 | MP0002971_abnormal_brown_adipose | 0.75095758 |
| 53 | MP0005376_homeostasis/metabolism_phenot | 0.73903676 |
| 54 | MP0001661_extended_life_span | 0.72883693 |
| 55 | MP0009780_abnormal_chondrocyte_physiolo | 0.71161609 |
| 56 | MP0009765_abnormal_xenobiotic_induced | 0.71126624 |
| 57 | MP0005334_abnormal_fat_pad | 0.70118419 |
| 58 | MP0001915_intracranial_hemorrhage | 0.68638566 |
| 59 | MP0001765_abnormal_ion_homeostasis | 0.67602361 |
| 60 | MP0005187_abnormal_penis_morphology | 0.67572684 |
| 61 | MP0010368_abnormal_lymphatic_system | 0.64542730 |
| 62 | MP0003329_amyloid_beta_deposits | 0.63016841 |
| 63 | MP0003690_abnormal_glial_cell | 0.62741335 |
| 64 | MP0005266_abnormal_metabolism | 0.62129283 |
| 65 | MP0002928_abnormal_bile_duct | 0.61999367 |
| 66 | MP0003879_abnormal_hair_cell | 0.61555920 |
| 67 | MP0005666_abnormal_adipose_tissue | 0.58167118 |
| 68 | MP0000230_abnormal_systemic_arterial | 0.56960361 |
| 69 | MP0002909_abnormal_adrenal_gland | 0.55358158 |
| 70 | MP0005448_abnormal_energy_balance | 0.54043281 |
| 71 | MP0005395_other_phenotype | 0.51124133 |
| 72 | MP0003638_abnormal_response/metabolism_ | 0.51060314 |
| 73 | MP0009053_abnormal_anal_canal | 0.49619623 |
| 74 | MP0005058_abnormal_lysosome_morphology | 0.49453187 |
| 75 | MP0002282_abnormal_trachea_morphology | 0.47922770 |
| 76 | MP0002168_other_aberrant_phenotype | 0.47174978 |
| 77 | MP0002796_impaired_skin_barrier | 0.45570692 |
| 78 | MP0003953_abnormal_hormone_level | 0.45487380 |
| 79 | MP0003300_gastrointestinal_ulcer | 0.44958102 |
| 80 | MP0000639_abnormal_adrenal_gland | 0.44737667 |
| 81 | * MP0006035_abnormal_mitochondrial_morpho | 0.44071171 |
| 82 | MP0002837_dystrophic_cardiac_calcinosis | 0.43124213 |
| 83 | MP0001944_abnormal_pancreas_morphology | 0.41639975 |
| 84 | MP0003724_increased_susceptibility_to | 0.41317964 |
| 85 | MP0001881_abnormal_mammary_gland | 0.40714344 |
| 86 | MP0008874_decreased_physiological_sensi | 0.39440736 |
| 87 | MP0005464_abnormal_platelet_physiology | 0.39087902 |
| 88 | MP0005551_abnormal_eye_electrophysiolog | 0.38629182 |
| 89 | MP0005379_endocrine/exocrine_gland_phen | 0.37749611 |
| 90 | MP0010234_abnormal_vibrissa_follicle | 0.36703229 |
| 91 | MP0008873_increased_physiological_sensi | 0.36595194 |
| 92 | MP0005023_abnormal_wound_healing | 0.35886241 |
| 93 | MP0003075_altered_response_to | 0.35750346 |
| 94 | MP0000538_abnormal_urinary_bladder | 0.34895239 |
| 95 | MP0004272_abnormal_basement_membrane | 0.34739680 |
| 96 | MP0009115_abnormal_fat_cell | 0.34501426 |
| 97 | MP0003718_maternal_effect | 0.33884303 |
| 98 | MP0003950_abnormal_plasma_membrane | 0.33767352 |
| 99 | MP0008872_abnormal_physiological_respon | 0.33664228 |
| 100 | MP0005164_abnormal_response_to | 0.33463827 |
| 101 | MP0004264_abnormal_extraembryonic_tissu | 0.33299884 |
| 102 | MP0009672_abnormal_birth_weight | 0.32827931 |
| 103 | MP0002135_abnormal_kidney_morphology | 0.32607286 |
| 104 | MP0005166_decreased_susceptibility_to | 0.32391831 |
| 105 | MP0002090_abnormal_vision | 0.32201130 |
| 106 | MP0003890_abnormal_embryonic-extraembry | 0.31956064 |
| 107 | MP0003959_abnormal_lean_body | 0.31757456 |
| 108 | MP0008961_abnormal_basal_metabolism | 0.31682036 |
| 109 | MP0002822_catalepsy | 0.31348066 |
| 110 | MP0004782_abnormal_surfactant_physiolog | 0.31259345 |
| 111 | MP0002970_abnormal_white_adipose | 0.30854151 |
| 112 | MP0004147_increased_porphyrin_level | 0.30658946 |
| 113 | MP0003436_decreased_susceptibility_to | 0.28785157 |
| 114 | MP0006082_CNS_inflammation | 0.28605511 |
| 115 | MP0001845_abnormal_inflammatory_respons | 0.28248594 |
| 116 | MP0000566_synostosis | 0.28232671 |
| 117 | MP0005248_abnormal_Harderian_gland | 0.27853823 |
| 118 | MP0001324_abnormal_eye_pigmentation | 0.27300489 |
| 119 | MP0001853_heart_inflammation | 0.26912931 |
| 120 | MP0003941_abnormal_skin_development | 0.26497342 |
| 121 | MP0003943_abnormal_hepatobiliary_system | 0.25433763 |
| 122 | MP0004883_abnormal_blood_vessel | 0.25380173 |
| 123 | MP0005646_abnormal_pituitary_gland | 0.24784742 |
| 124 | MP0005197_abnormal_uvea_morphology | 0.24536836 |
| 125 | MP0005330_cardiomyopathy | 0.24499162 |
| 126 | MP0008775_abnormal_heart_ventricle | 0.24434988 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 6.79737609 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.79540658 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.36574358 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.05169515 |
| 5 | Xanthomatosis (HP:0000991) | 6.00733122 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 5.86895551 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 5.45116439 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 4.85727014 |
| 9 | Hyperammonemia (HP:0001987) | 4.71939710 |
| 10 | Hyperglycinuria (HP:0003108) | 4.67846385 |
| 11 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.61790289 |
| 12 | Ketosis (HP:0001946) | 4.58753805 |
| 13 | Hyperglycinemia (HP:0002154) | 4.58263874 |
| 14 | Abnormality of glycine metabolism (HP:0010895) | 4.46222702 |
| 15 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.46222702 |
| 16 | Epidermoid cyst (HP:0200040) | 4.37040265 |
| 17 | Hypolipoproteinemia (HP:0010981) | 4.32680335 |
| 18 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.31979991 |
| 19 | Complement deficiency (HP:0004431) | 4.28364907 |
| 20 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.20494248 |
| 21 | Joint hemorrhage (HP:0005261) | 4.12156084 |
| 22 | Hypoglycemic coma (HP:0001325) | 3.99813822 |
| 23 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.96056439 |
| 24 | Fat malabsorption (HP:0002630) | 3.95264690 |
| 25 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.94965870 |
| 26 | Abnormality of methionine metabolism (HP:0010901) | 3.82052428 |
| 27 | Abnormality of the common coagulation pathway (HP:0010990) | 3.76796344 |
| 28 | Hypoalphalipoproteinemia (HP:0003233) | 3.70012652 |
| 29 | Ketoacidosis (HP:0001993) | 3.69274683 |
| 30 | Conjugated hyperbilirubinemia (HP:0002908) | 3.55838677 |
| 31 | Gout (HP:0001997) | 3.54235010 |
| 32 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.47971919 |
| 33 | Nephritis (HP:0000123) | 3.42548189 |
| 34 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.39479114 |
| 35 | Hypercholesterolemia (HP:0003124) | 3.39131934 |
| 36 | Abnormality of nucleobase metabolism (HP:0010932) | 3.35644902 |
| 37 | Abnormality of purine metabolism (HP:0004352) | 3.33727796 |
| 38 | Delayed CNS myelination (HP:0002188) | 3.32814042 |
| 39 | Hyperbilirubinemia (HP:0002904) | 3.20012165 |
| 40 | Abnormality of the intrinsic pathway (HP:0010989) | 3.17749993 |
| 41 | Abnormality of serum amino acid levels (HP:0003112) | 3.10690455 |
| 42 | Abnormality of complement system (HP:0005339) | 3.06153899 |
| 43 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.04709367 |
| 44 | Dicarboxylic aciduria (HP:0003215) | 3.04709367 |
| 45 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.98346656 |
| 46 | Osteomalacia (HP:0002749) | 2.97887871 |
| 47 | * Metabolic acidosis (HP:0001942) | 2.92416386 |
| 48 | Hepatocellular carcinoma (HP:0001402) | 2.87400073 |
| 49 | Steatorrhea (HP:0002570) | 2.87121302 |
| 50 | Proximal tubulopathy (HP:0000114) | 2.78895814 |
| 51 | Generalized aminoaciduria (HP:0002909) | 2.78758558 |
| 52 | Lethargy (HP:0001254) | 2.78752282 |
| 53 | Gingival bleeding (HP:0000225) | 2.76051182 |
| 54 | Vascular calcification (HP:0004934) | 2.73942851 |
| 55 | Skin nodule (HP:0200036) | 2.68746943 |
| 56 | Malnutrition (HP:0004395) | 2.63559881 |
| 57 | Alkalosis (HP:0001948) | 2.58370098 |
| 58 | Increased purine levels (HP:0004368) | 2.57166340 |
| 59 | Hyperuricemia (HP:0002149) | 2.57166340 |
| 60 | Spastic diplegia (HP:0001264) | 2.56641199 |
| 61 | Acanthocytosis (HP:0001927) | 2.56186776 |
| 62 | Myocardial infarction (HP:0001658) | 2.53102976 |
| 63 | Hemorrhage of the eye (HP:0011885) | 2.51573981 |
| 64 | Irritability (HP:0000737) | 2.45706729 |
| 65 | Cardiovascular calcification (HP:0011915) | 2.43053670 |
| 66 | Hypoglycemic seizures (HP:0002173) | 2.42664325 |
| 67 | Fair hair (HP:0002286) | 2.41423327 |
| 68 | Vomiting (HP:0002013) | 2.38706130 |
| 69 | Cerebral edema (HP:0002181) | 2.38648363 |
| 70 | Hypochromic microcytic anemia (HP:0004840) | 2.37706607 |
| 71 | Hydroxyprolinuria (HP:0003080) | 2.36426603 |
| 72 | Abnormality of proline metabolism (HP:0010907) | 2.36426603 |
| 73 | Neonatal onset (HP:0003623) | 2.35965185 |
| 74 | Reduced antithrombin III activity (HP:0001976) | 2.34573060 |
| 75 | Sensorimotor neuropathy (HP:0007141) | 2.34183294 |
| 76 | Spontaneous abortion (HP:0005268) | 2.33766476 |
| 77 | Enlarged kidneys (HP:0000105) | 2.29001125 |
| 78 | Systemic lupus erythematosus (HP:0002725) | 2.26155627 |
| 79 | Abnormal gallbladder morphology (HP:0012437) | 2.25756075 |
| 80 | Pancreatitis (HP:0001733) | 2.20957925 |
| 81 | Cholelithiasis (HP:0001081) | 2.19703963 |
| 82 | Abnormal gallbladder physiology (HP:0012438) | 2.18622741 |
| 83 | Cholecystitis (HP:0001082) | 2.18622741 |
| 84 | Potter facies (HP:0002009) | 2.18307578 |
| 85 | Facial shape deformation (HP:0011334) | 2.18307578 |
| 86 | Late onset (HP:0003584) | 2.18236788 |
| 87 | Thrombophlebitis (HP:0004418) | 2.17813132 |
| 88 | Brushfield spots (HP:0001088) | 2.12892284 |
| 89 | Mitral stenosis (HP:0001718) | 2.11801741 |
| 90 | Esophageal varix (HP:0002040) | 2.07369851 |
| 91 | Arthropathy (HP:0003040) | 2.07013250 |
| 92 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.06363816 |
| 93 | Renal cortical cysts (HP:0000803) | 2.05127564 |
| 94 | Glomerulonephritis (HP:0000099) | 2.05079184 |
| 95 | * Glycosuria (HP:0003076) | 2.02186113 |
| 96 | * Abnormality of urine glucose concentration (HP:0011016) | 2.02186113 |
| 97 | Abnormal cartilage morphology (HP:0002763) | 2.01383840 |
| 98 | Purpura (HP:0000979) | 1.98722412 |
| 99 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.97020434 |
| 100 | Opisthotonus (HP:0002179) | 1.92538288 |
| 101 | * Hyperphosphaturia (HP:0003109) | 1.91561438 |
| 102 | Amyloidosis (HP:0011034) | 1.89787383 |
| 103 | Bifid scrotum (HP:0000048) | 1.89663013 |
| 104 | Nausea (HP:0002018) | 1.89422157 |
| 105 | Confusion (HP:0001289) | 1.89223077 |
| 106 | * Rickets (HP:0002748) | 1.89053587 |
| 107 | Abnormality of the gallbladder (HP:0005264) | 1.87810860 |
| 108 | Abnormality of vitamin metabolism (HP:0100508) | 1.86672346 |
| 109 | Poikilocytosis (HP:0004447) | 1.85871925 |
| 110 | Menorrhagia (HP:0000132) | 1.84612386 |
| 111 | Increased serum pyruvate (HP:0003542) | 1.84446552 |
| 112 | Nephrolithiasis (HP:0000787) | 1.83950414 |
| 113 | Elevated hepatic transaminases (HP:0002910) | 1.82262461 |
| 114 | Abnormal biliary tract physiology (HP:0012439) | 1.82055821 |
| 115 | Bile duct proliferation (HP:0001408) | 1.82055821 |
| 116 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.81554301 |
| 117 | Hypophosphatemic rickets (HP:0004912) | 1.80738931 |
| 118 | Joint swelling (HP:0001386) | 1.80377879 |
| 119 | Retinal atrophy (HP:0001105) | 1.75930759 |
| 120 | Pulmonary embolism (HP:0002204) | 1.72307427 |
| 121 | Elevated alkaline phosphatase (HP:0003155) | 1.69495930 |
| 122 | Abnormal tarsal ossification (HP:0008369) | 1.68664191 |
| 123 | Generalized hypopigmentation of hair (HP:0011358) | 1.66048805 |
| 124 | Cerebral palsy (HP:0100021) | 1.65330867 |
| 125 | Increased mean platelet volume (HP:0011877) | 1.65273031 |
| 126 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.60329238 |
| 127 | Abnormality of glycolysis (HP:0004366) | 1.59218302 |
| 128 | Hypothermia (HP:0002045) | 1.58993736 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.20700303 |
| 2 | SIK1 | 3.97169506 |
| 3 | FGFR4 | 3.89994071 |
| 4 | ERN1 | 3.80100392 |
| 5 | INSRR | 2.89976091 |
| 6 | ACVR1B | 2.67234997 |
| 7 | WNK3 | 2.66555459 |
| 8 | WNK4 | 2.47538778 |
| 9 | TAOK3 | 2.41270812 |
| 10 | MST1R | 2.37035819 |
| 11 | PIK3CA | 2.31468406 |
| 12 | ERBB4 | 2.29146753 |
| 13 | PKN2 | 2.20974087 |
| 14 | OXSR1 | 2.18874511 |
| 15 | MAP3K12 | 2.05166071 |
| 16 | MAP2K4 | 1.91436266 |
| 17 | PIK3CG | 1.89408517 |
| 18 | TRIB3 | 1.71430940 |
| 19 | FLT3 | 1.69805690 |
| 20 | MAPK11 | 1.69313110 |
| 21 | EIF2AK3 | 1.66122850 |
| 22 | FRK | 1.60898685 |
| 23 | MYLK | 1.59200917 |
| 24 | FER | 1.56618090 |
| 25 | LATS1 | 1.52695490 |
| 26 | STK38L | 1.46499056 |
| 27 | BCR | 1.41619729 |
| 28 | ABL2 | 1.39486182 |
| 29 | PTK6 | 1.39271583 |
| 30 | BRSK2 | 1.38714507 |
| 31 | TYK2 | 1.38025135 |
| 32 | NLK | 1.36565032 |
| 33 | MST4 | 1.35316002 |
| 34 | MAP3K7 | 1.31846699 |
| 35 | PINK1 | 1.31530483 |
| 36 | AKT3 | 1.31135185 |
| 37 | DAPK2 | 1.30310460 |
| 38 | NEK9 | 1.28898391 |
| 39 | MAPKAPK3 | 1.28437890 |
| 40 | PRKAA2 | 1.25805283 |
| 41 | FGFR2 | 1.22546592 |
| 42 | BMPR1B | 1.22094014 |
| 43 | EIF2AK1 | 1.21409543 |
| 44 | KDR | 1.16959754 |
| 45 | PDK4 | 1.13505412 |
| 46 | PDK3 | 1.13505412 |
| 47 | GRK6 | 1.10446018 |
| 48 | JAK2 | 1.08159496 |
| 49 | CASK | 1.05009902 |
| 50 | MAP3K10 | 1.04012283 |
| 51 | TNIK | 1.02220797 |
| 52 | MAP3K4 | 1.01376829 |
| 53 | NTRK3 | 1.00291034 |
| 54 | MAP4K2 | 0.99742917 |
| 55 | CAMK1D | 0.98327598 |
| 56 | PBK | 0.97060050 |
| 57 | MET | 0.93299688 |
| 58 | ERBB3 | 0.92888255 |
| 59 | MAP3K14 | 0.92673602 |
| 60 | EPHB1 | 0.91853710 |
| 61 | PRKCE | 0.90908645 |
| 62 | MAP3K3 | 0.89722627 |
| 63 | TBK1 | 0.87761619 |
| 64 | MAP2K3 | 0.87318148 |
| 65 | SGK3 | 0.86851853 |
| 66 | SGK223 | 0.86479726 |
| 67 | SGK494 | 0.86479726 |
| 68 | MAPK4 | 0.85760591 |
| 69 | TIE1 | 0.85139402 |
| 70 | PRKCZ | 0.84859282 |
| 71 | TRIM28 | 0.84717134 |
| 72 | JAK1 | 0.84308217 |
| 73 | STK39 | 0.83406145 |
| 74 | PRKAA1 | 0.82826362 |
| 75 | GSK3A | 0.82365851 |
| 76 | MAPK15 | 0.80385717 |
| 77 | TRPM7 | 0.78976254 |
| 78 | ERBB2 | 0.77618075 |
| 79 | STK3 | 0.75159696 |
| 80 | IRAK3 | 0.74159448 |
| 81 | PRKACG | 0.72470614 |
| 82 | DYRK1B | 0.72263179 |
| 83 | CAMKK2 | 0.71756028 |
| 84 | SGK2 | 0.70416335 |
| 85 | RIPK1 | 0.69350134 |
| 86 | TGFBR2 | 0.69324829 |
| 87 | PRKG1 | 0.68344676 |
| 88 | MUSK | 0.68046846 |
| 89 | PDPK1 | 0.67757239 |
| 90 | MAPK12 | 0.67575103 |
| 91 | PDK2 | 0.65572536 |
| 92 | PRKACA | 0.63272969 |
| 93 | CSK | 0.62660853 |
| 94 | CDK6 | 0.61933424 |
| 95 | SCYL2 | 0.61405244 |
| 96 | PTK2 | 0.60390589 |
| 97 | NUAK1 | 0.59149501 |
| 98 | MAP3K11 | 0.56749926 |
| 99 | CSNK1E | 0.55724085 |
| 100 | PRKACB | 0.54774559 |
| 101 | CAMK1G | 0.53960474 |
| 102 | FGFR1 | 0.51218099 |
| 103 | CAMK2G | 0.50707202 |
| 104 | NEK1 | 0.50373517 |
| 105 | MAP2K6 | 0.48448361 |
| 106 | PDK1 | 0.48244630 |
| 107 | CSNK1D | 0.47641914 |
| 108 | PRKCQ | 0.47250531 |
| 109 | FGFR3 | 0.46927359 |
| 110 | PRKCB | 0.45830280 |
| 111 | EPHA2 | 0.45536119 |
| 112 | MAP2K7 | 0.44374113 |
| 113 | CSNK1G1 | 0.43741788 |
| 114 | CSNK1A1 | 0.43486935 |
| 115 | CSF1R | 0.41801538 |
| 116 | IGF1R | 0.41657213 |
| 117 | ADRBK2 | 0.41533207 |
| 118 | EPHA3 | 0.40825168 |
| 119 | ZAK | 0.40607535 |
| 120 | MAPK7 | 0.37665541 |
| 121 | CAMK2D | 0.37608885 |
| 122 | RET | 0.37339016 |
| 123 | RPS6KA3 | 0.36970359 |
| 124 | CSNK2A2 | 0.35478407 |
| 125 | MTOR | 0.34420856 |
| 126 | MAP2K1 | 0.34025718 |
| 127 | STK38 | 0.34020320 |
| 128 | IKBKE | 0.32216737 |
| 129 | ICK | 0.32042804 |
| 130 | MAP3K13 | 0.31500233 |
| 131 | GRK1 | 0.30951135 |
| 132 | PAK3 | 0.29411750 |
| 133 | MAP3K5 | 0.28284938 |
| 134 | IRAK2 | 0.26860640 |
| 135 | MAP3K2 | 0.26627134 |
| 136 | EGFR | 0.24885475 |
| 137 | PRKCA | 0.24862525 |
| 138 | CAMK4 | 0.24217174 |
| 139 | PRKCG | 0.23575609 |
| 140 | CDK4 | 0.23173139 |
| 141 | MAP2K2 | 0.22748882 |
| 142 | MAP3K6 | 0.22017282 |
| 143 | BMX | 0.21868177 |
| 144 | LRRK2 | 0.20219408 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.15032824 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.45229085 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.24671171 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.08755986 |
| 5 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.07905800 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.78205975 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.74671598 |
| 8 | * Fatty acid degradation_Homo sapiens_hsa00071 | 2.73517576 |
| 9 | * Tryptophan metabolism_Homo sapiens_hsa00380 | 2.66322540 |
| 10 | * Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.64817000 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.44017618 |
| 12 | * Butanoate metabolism_Homo sapiens_hsa00650 | 2.38769397 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.37110794 |
| 14 | * Peroxisome_Homo sapiens_hsa04146 | 2.28130507 |
| 15 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.24750351 |
| 16 | * Propanoate metabolism_Homo sapiens_hsa00640 | 2.22380107 |
| 17 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.06712992 |
| 18 | * Fatty acid metabolism_Homo sapiens_hsa01212 | 2.04564840 |
| 19 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.98524649 |
| 20 | * PPAR signaling pathway_Homo sapiens_hsa03320 | 1.96988945 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.82782624 |
| 22 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.77869650 |
| 23 | * beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.76726283 |
| 24 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.76382339 |
| 25 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.74520939 |
| 26 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.72297335 |
| 27 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.68199294 |
| 28 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.67640152 |
| 29 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.61406213 |
| 30 | Retinol metabolism_Homo sapiens_hsa00830 | 1.59330203 |
| 31 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.59272412 |
| 32 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.58663212 |
| 33 | Bile secretion_Homo sapiens_hsa04976 | 1.58453782 |
| 34 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.49208999 |
| 35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.43152820 |
| 36 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.42531315 |
| 37 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.41084763 |
| 38 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.37912503 |
| 39 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.31213414 |
| 40 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.28952897 |
| 41 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.26916504 |
| 42 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.25667092 |
| 43 | * Carbon metabolism_Homo sapiens_hsa01200 | 1.23756532 |
| 44 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.21819085 |
| 45 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.20885740 |
| 46 | ABC transporters_Homo sapiens_hsa02010 | 1.19732940 |
| 47 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.19250901 |
| 48 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.19235171 |
| 49 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.17367889 |
| 50 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.16148240 |
| 51 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.14792132 |
| 52 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.11868504 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.02972742 |
| 54 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.96429315 |
| 55 | * Lysine degradation_Homo sapiens_hsa00310 | 0.87649418 |
| 56 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.87610353 |
| 57 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.86549701 |
| 58 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.84003372 |
| 59 | Sulfur relay system_Homo sapiens_hsa04122 | 0.83093051 |
| 60 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.80708781 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.79873891 |
| 62 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.78907950 |
| 63 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.78412400 |
| 64 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.68780194 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.59791239 |
| 66 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.58777750 |
| 67 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.48084062 |
| 68 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.32275325 |
| 69 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.32177761 |
| 70 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.28836403 |
| 71 | Galactose metabolism_Homo sapiens_hsa00052 | 0.27607934 |
| 72 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.27523483 |
| 73 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.27149413 |
| 74 | Insulin resistance_Homo sapiens_hsa04931 | 0.24783167 |
| 75 | Prion diseases_Homo sapiens_hsa05020 | 0.14187307 |
| 76 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.13756937 |
| 77 | Pertussis_Homo sapiens_hsa05133 | 0.11178792 |
| 78 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.10681690 |
| 79 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.10174205 |
| 80 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.05657715 |
| 81 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.04992544 |
| 82 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.00731021 |
| 83 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2290617 |
| 84 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2254898 |
| 85 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2174361 |
| 86 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | -0.2124252 |
| 87 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.2044593 |
| 88 | Other glycan degradation_Homo sapiens_hsa00511 | -0.1971812 |
| 89 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1924545 |
| 90 | Lysosome_Homo sapiens_hsa04142 | -0.1920949 |
| 91 | Protein export_Homo sapiens_hsa03060 | -0.1916042 |
| 92 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1783623 |
| 93 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1693833 |
| 94 | Hepatitis C_Homo sapiens_hsa05160 | -0.1623401 |
| 95 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1480000 |
| 96 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1415117 |
| 97 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1138315 |
| 98 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1094841 |
| 99 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1075091 |
| 100 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1053685 |
| 101 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1017555 |
| 102 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0911332 |
| 103 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0890006 |
| 104 | Mineral absorption_Homo sapiens_hsa04978 | -0.0881795 |
| 105 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0762016 |
| 106 | Circadian rhythm_Homo sapiens_hsa04710 | -0.0753185 |
| 107 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.0571409 |
| 108 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0397810 |
| 109 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.0285027 |
| 110 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0099129 |
| 111 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0045930 |

